Pharmacotherapy to enhance arousal: what is known and what is not

Progress in Brain Research

Volumn 177, Issue C, 2009, Pages 293-316

  Zafonte, Ross ^a   Hammond, Flora ^b   Dennison, Andrew ^b   Chew, Effie ^a  

^a and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

^b CAROLINAS MEDICAL CENTER   (United States)

Author keywords

arousal; brain injury; clinical trial; neurotransmitter; pharmacotherapy

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 AMINOBUTYRIC ACID; ACETYLCHOLINE; AMANTADINE; AMITRIPTYLINE; APOMORPHINE; ATOMOXETINE; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; CARBIDOPA PLUS LEVODOPA; CENTRAL STIMULANT AGENT; DESIPRAMINE; DEXAMPHETAMINE; DOPAMINE; GLUTAMIC ACID; HISTAMINE; KALLIKREIN; KININ; METHYLPHENIDATE; MODAFINIL; MUSCIMOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALTREXONE; NORADRENALIN; OREXIN; PRAMIPEXOLE; SEROTONIN; SERTRALINE; UNINDEXED DRUG; ZOLPIDEM; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

AROUSAL; BRAIN DEPTH STIMULATION; BRAIN HYPOXIA; BRAIN ISCHEMIA; CLINICAL TRIAL; COMPLEX REGIONAL PAIN SYNDROME; CONSCIOUSNESS DISORDER; CONTINUOUS INFUSION; DOPAMINERGIC SYSTEM; DORSAL RAPHE NUCLEUS; FOREBRAIN; GABAERGIC SYSTEM; HUMAN; HYPOTHALAMUS; LOCUS CERULEUS; LOW DRUG DOSE; MESENCEPHALON; MINIMALLY CONSCIOUS STATE; NARCOLEPSY; NEUROMODULATION; NEUROPHYSIOLOGY; NEUROTRANSMITTER RELEASE; NONHUMAN; NONREM SLEEP; NORADRENERGIC SYSTEM; PERSISTENT VEGETATIVE STATE; PRIORITY JOURNAL; REM SLEEP; RESTLESSNESS; RETICULAR FORMATION; REVIEW; SEROTONINERGIC SYSTEM; TEGMENTUM; THALAMOCORTICAL TRACT; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN; BRAIN INJURY; CONSCIOUSNESS; DISEASE MODEL; DRUG EFFECT; DRUG THERAPY; METABOLISM; METHODOLOGY; PATHOLOGY;

ANIMALS; AROUSAL; BRAIN; BRAIN INJURIES; CONSCIOUSNESS; DISEASE MODELS, ANIMAL; DRUG THERAPY; HUMANS; NEUROTRANSMITTER AGENTS;

EID: 73949126517     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(09)17720-8     Document Type: Review

References (164)

1. Adams J.H., Doyle D., Ford I., Gennarelli T.A., Graham D.I., and McLellan D.R. Diffuse axonal injury in head injury: Definition, diagnosis and grading. Histopathology 15 (1989) 49-59
2. Alban J.P., Hopson M.M., Ly V., and Whyte J. Effect of methylphenidate on vital signs and adverse effects in adults with traumatic brain injury. American Journal of Physical Medicine and Rehabilitation 83 (2004) 131-137
3. Arciniegas D.B. The cholinergic hypothesis of cognitive impairment caused by traumatic brain injury. Current Psychiatry Reports 5 (2003) 391-399
4. Arciniegas D.B., and Silver J.M. Pharmacotherapy of posttraumatic cognitive impairments. Behavioural Neurology 17 (2006) 25-42
5. Armstead W.M. Role of opioids in the physiologic and pathophysiologic control of the cerebral circulation. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 214 (1997) 210-221
6. Arpa J., and De Andres I. Re-examination of the effects of raphe lesions on the sleep/wakefulness cycle states of cats. Journal of Sleep Research 2 (1993) 96-102
7. Bakay R.A., Sweeney K.M., and Wood J.H. Pathophysiology of cerebrospinal fluid in head injury: Part 1. Pathological changes in cerebrospinal fluid solute composition after traumatic injury. Neurosurgery 18 (1986) 234-243
8. Baker A.J., Moulton R.J., MacMillan V.H., and Shedden P.M. Excitatory amino acids in cerebrospinal fluid following traumatic brain injury in humans. Journal of Neurosurgery 79 (1993) 369-372
9. Baldo B.A., Daniel R.A., Berridge C.W., and Kelley A.E. Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. The Journal of Comparative Neurology 464 (2003) 220-237
10. Baranova A.I., Whiting M.D., and Hamm R.J. Delayed, post-injury treatment with aniracetam improves cognitive performance after traumatic brain injury in rats. Journal of Neurotrauma 23 (2006) 1233-1240
11. Baumann C.R., Stocker R., Imhof H.G., Trentz O., Hersberger M., Mignot E., et al. Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury. Neurology 65 (2005) 147-149
12. Benarroch E.E. The midline and intralaminar thalamic nuclei: Anatomic and functional specificity and implications in neurologic disease. Neurology 71 (2008) 944-949
13. Berridge C.W. Noradrenergic modulation of arousal. Brain Research Reviews 58 (2008) 1-17
14. Boggio P.S., Nunes A., Rigonatti S.P., Nitsche M.A., Pascual-Leone A., and Fregni F. Repeated sessions of noninvasive brain DC stimulation is associated with motor function improvement in stroke patients. Restorative Neurology and Neuroscience 25 (2007) 123-129
15. Boly M., Faymonville M.E., Peigneux P., Lambermont B., Damas P., Del F.G., et al. Auditory processing in severely brain injured patients: Differences between the minimally conscious state and the persistent vegetative state. Archives of Neurology 61 (2004) 233-238
16. Bornstein MB. Presence and action of acetylcholine in experimental brain injury. Journal of Neurophysiology 9 (1946) 349-366
17. Caine D., and Watson J.D. Neuropsychological and neuropathological sequelae of cerebral anoxia: A critical review. Journal of the International Neuropsychological Society 6 (2000) 86-99
18. Calvanio R., Burke D.T., Kim H.J., Cheng J., Lepak P., Leonard J., et al. Naltrexone: Effects on motor function, speech, and activities of daily living in a patient with traumatic brain injury. Brain Injury 14 (2000) 933-942
19. Chalmers D. What is a neural correlate of consciousness?. In: Metzinger T. (Ed). Neural correlates of consciousness: Empirical and conceptual questions (2000), MIT Press, Cambridge, MA 17-40
20. Cheng J.P., Hoffman A.N., Zafonte R.D., and Kline A.E. A delayed and chronic treatment regimen with the 5-HT1A receptor agonist 8-OH-DPAT after cortical impact injury facilitates motor recovery and acquisition of spatial learning. Behavioural Brain Research 194 (2008) 79-85
21. Ciallella J.R., Yan H.Q., Ma X., Wolfson B.M., Marion D.W., DeKosky S.T., et al. Chronic effects of traumatic brain injury on hippocampal vesicular acetylcholine transporter and M2 muscarinic receptor protein in rats. Experimental Neurology 152 (1998) 11-19
22. Claudet I., and Marechal C. Status epilepticus in a pediatric patient with amantadine overdose. Pediatric Neurology 40 (2009) 120-122
23. Clauss R., and Nel W. Drug induced arousal from the permanent vegetative state. NeuroRehabilitation 21 (2006) 23-28
24. Clauss R.P., Guldenpfennig W.M., Nel H.W., Sathekge M.M., and Venkannagari R.R. Extraordinary arousal from semi-comatose state on zolpidem. A case report. South African Medical Journal 90 (2000) 68-72
25. Clauss R.P., van der Merwe C.E., and Nel H.W. Arousal from a semi-comatose state on zolpidem. South African Medical Journal 91 (2001) 788-789
26. Clifton G.L., Ziegler M.G., Grossman R.G., Clifton G.L., Ziegler M.G., and Grossman R.G. Circulating catecholamines and sympathetic activity after head injury. Neurosurgery 8 (1981) 10-14
27. Cohen S.I., and Duong T.T. Increased arousal in a patient with anoxic brain injury after administration of zolpidem. American Journal of Physical Medicine and Rehabilitation 87 (2008) 229-231
28. Decavel C., Van den Pol A.N., Decavel C., and Van den Pol A.N. GABA: A dominant neurotransmitter in the hypothalamus. The Journal of Comparative Neurology 302 (1990) 1019-1037
29. Dement W., and Henriksen S. Biogenic amines, phasic events, and behavior. Pharmacology and the Future of Man (1973) 74-89
30. Dixon C.E., Kraus M.F., Kline A.E., Ma X., Yan H.Q., Griffith R.G., et al. Amantadine improves water maze performance without affecting motor behavior following traumatic brain injury in rats. Restorative Neurology and Neuroscience 14 (1999) 285-294
31. Dixon C.E., Liu S.J., Jenkins L.W., Bhattachargee M., Whitson J.S., Yang K., et al. Time course of increased vulnerability of cholinergic neurotransmission following traumatic brain injury in the rat. Behavioural Brain Research 70 (1995) 125-131
32. Drake Jr. M.E., Pakalnis A., Denio L.S., and Phillips B. Amantadine hydrochloride for refractory generalized epilepsy in adults. Acta Neurologica Belgica 91 (1991) 159-164
33. Duan W., Peng Q., Masuda N., Ford E., Tryggestad E., Ladenheim B., et al. Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease. Neurobiology of Disease 30 (2008) 312-322
34. Dugovic C., Shelton J.E., Aluisio L.E., Fraser I.C., Jiang X., Sutton S.W., et al. Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat. The Journal of Pharmacology and Experimental Therapeutics 330 1 (2009) 142-151
35. Elovic E. Use of provigil for underarousal following TBI. The Journal of Head Trauma Rehabilitation 15 (2000) 1068-1071
36. Faden A.I., Demediuk P., Panter S.S., Vink R., Faden A.I., Demediuk P., et al. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244 (1989) 798-800
37. Feeney D.M., Gonzalez A., and Law W.A. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science 217 (1982) 855-857
38. Ford B., Holmes C.J., Mainville L., Jones B.E., Ford B., Holmes C.J., et al. GABAergic neurons in the rat pontomesencephalic tegmentum: Codistribution with cholinergic and other tegmental neurons projecting to the posterior lateral hypothalamus. The Journal of Comparative Neurology 363 (1995) 177-196
39. Fort P., Khateb A., Pegna A., Muhlethaler M., Jones B.E., Fort P., et al. Noradrenergic modulation of cholinergic nucleus basalis neurons demonstrated by in vitro pharmacological and immunohistochemical evidence in the guinea-pig brain. The European Journal of Neuroscience 7 (1995) 1502-1511
40. Fridman E.A., Calvar J., Bonetto M., Gamzu E., Krimchansky B.Z., Meli F., et al. Fast awakening from minimally conscious state with apomorphine. Brain Injury 23 (2009) 172-177
41. Globus M.Y., Busto R., Dietrich W.D., Martinez E., Valdes I., Ginsberg M.D., et al. Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis. Journal of Neurochemistry 51 (1988) 1455-1464
42. Globus M.Y., Busto R., Dietrich W.D., Martinez E., Valdes I., Ginsberg M.D., et al. Direct evidence for acute and massive norepinephrine release in the hippocampus during transient ischemia. Journal of Cerebral Blood Flow and Metabolism 9 (1989) 892-896
43. Globus M.Y., Wester P., Busto R., Dietrich W.D., Globus M.Y., Wester P., et al. Ischemia-induced extracellular release of serotonin plays a role in CA1 neuronal cell death in rats. Stroke 23 (1992) 1595-1601
44. Goldstein L.B., and Bullman S. Differential effects of haloperidol and clozapine on motor recovery after sensorimotor cortex injury in rats. Neurorehabilitation and Neural Repair 16 (2002) 321-325
45. Gualtieri T., Chandler M., Coons T.B., and Brown L.T. Amantadine: A new clinical profile for traumatic brain injury. Clinical Neuropharmacology 12 (1989) 258-270
46. Gucuyener K., Erdemoglu A.K., Senol S., Serdaroglu A., Soysal S., and Kockar A.I. Use of methylphenidate for attention-deficit hyperactivity disorder in patients with epilepsy or electroencephalographic abnormalities. Journal of Child Neurology 18 (2003) 109-112
47. Haig A.J., and Ruess J.M. Recovery from vegetative state of six months' duration associated with Sinemet (levodopa/carbidopa). Archives of Physical Medicine and Rehabilitation 71 (1990) 1081-1083
48. Hamill R.W., Woolf P.D., McDonald J.V., Lee L.A., Kelly M., Hamill R.W., et al. Catecholamines predict outcome in traumatic brain injury. Annals of Neurology 21 (1987) 438-443
49. Hayes R.L., Lyeth B.G., Jenkins L.W., Zimmerman R., McIntosh T.K., Clifton G.L., et al. Possible protective effect of endogenous opioids in traumatic brain injury. Journal of Neurosurgery 72 (1990) 252-261
50. Hemmer S.A., Pasternak J.F., Zecker S.G., and Trommer B.L. Stimulant therapy and seizure risk in children with ADHD. Pediatric Neurology 24 (2001) 99-102
51. Hobson J.A., McCarley R.W., Wyzinski P.W., Hobson J.A., McCarley R.W., and Wyzinski P.W. Sleep cycle oscillation: Reciprocal discharge by two brainstem neuronal groups. Science 189 (1975) 55-58
52. Hughes S., Colantonio A., Santaguida P.L., and Paton T. Amantadine to enhance readiness for rehabilitation following severe traumatic brain injury. Brain Injury 19 (2005) 1197-1206
53. Hummel F., Celnik P., Giraux P., Floel A., Wu W.H., Gerloff C., et al. Effects of non-invasive cortical stimulation on skilled motor function in chronic stroke. Brain 128 (2005) 490-499
54. Ito T., Shibata K., Watanabe A., and Akabane J. Neuroleptic malignant syndrome following withdrawal of amantadine in a patient with influenza A encephalopathy. European Journal of Pediatric Surgery 160 (2001) 401
55. Jacogs B.L., Asher R., Dement W.C., Jacogs B.L., Asher R., and Dement W.C. Electrophysiological and behavioral effects of electrical stimulation of the raphe nuclei in cats. Physiology and Behavior 11 (1973) 489-495
56. Jha A., Weintraub A., Allshouse A., Morey C., Cusick C., Kittelson J., et al. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. The Journal of Head Trauma Rehabilitation 23 (2008) 52-63
57. Jones, B. E. (1995). Reticular formation. Cytoarchitecture transmitters and projections. In: The rat nervous system (pp. 155-171). New South Wales, Australia: Academic Press.
58. Jones B.E., Cuello A.C., Jones B.E., and Cuello A.C. Afferents to the basal forebrain cholinergic cell area from pontomesencephalic - catecholamine, serotonin, and acetylcholine - neurons. Neuroscience 31 (1989) 37-61
59. Jones B.E., and Jones B.E. Arousal systems. Frontiers in bioscience 8 (2003) s438-s451
60. Jones B.E., and Jones B.E. Modulation of cortical activation and behavioral arousal by cholinergic and orexinergic systems. Annals of the New York Academy of Sciences 1129 (2008) 26-34
61. Kaneko T., Itoh K., Shigemoto R., Mizuno N., Kaneko T., Itoh K., et al. Glutaminase-like immunoreactivity in the lower brainstem and cerebellum of the adult rat. Neuroscience 32 (1989) 79-98
62. Kanthan R., Shuaib A., Griebel R., el Alazounni H., Miyashita H., Kalra J., et al. Evaluation of monoaminergic neurotransmitters in the acute focal ischemic human brain model by intracerebral in vivo microdialysis. Neurochemical Research 21 (1996) 563-566
63. Karakucuk E.I., Pasaoglu H., Pasaoglu A., Oktem S., Karakucuk E.I., Pasaoglu H., et al. Endogenous neuropeptides in patients with acute traumatic head injury. II: Changes in the levels of cerebrospinal fluid substance P, serotonin and lipid peroxidation products in patients with head trauma. Neuropeptides 31 (1997) 259-263
64. Ker K., Perel P., and Blackhall K. Beta-2 receptor antagonists for traumatic brain injury: A systematic review of controlled trials in animal models. CNS Neuroscience and Therapeutics 15 (2009) 52-64
65. Khateb A., Fort P., Alonso A., Jones B.E., Muhlethaler M., Khateb A., et al. Pharmacological and immunohistochemical evidence for serotonergic modulation of cholinergic nucleus basalis neurons. The European Journal of Neuroscience 5 (1993) 541-547
66. Khateb A., Fort P., Pegna A., Jones B.E., Muhlethaler M., Khateb A., et al. Cholinergic nucleus basalis neurons are excited by histamine in vitro. Neuroscience 69 (1995) 495-506
67. Khateb A., Fort P., Serafin M., Jones B.E., Muhlethaler M., Khateb A., et al. Rhythmical bursts induced by NMDA in guinea-pig cholinergic nucleus basalis neurones in vitro. The Journal of Physiology (London) 487 (1995) 623-638
68. Kline A.E., Hoffman A.N., Cheng J.P., Zafonte R.D., and Massucci J.L. Chronic administration of antipsychotics impede behavioral recovery after experimental traumatic brain injury. Neuroscience Letters 448 (2008) 263-267
69. Kline A.E., Massucci J.L., Dixon C.E., Zafonte R.D., and Bolinger B.D. The therapeutic efficacy conferred by the 5-HT(1A) receptor agonist 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) after experimental traumatic brain injury is not mediated by concomitant hypothermia. Journal of Neurotrauma 21 (2004) 175-185
70. Kline A.E., Massucci J.L., Ma X., Zafonte R.D., and Dixon C.E. Bromocriptine reduces lipid peroxidation and enhances spatial learning and hippocampal neuron survival in a rodent model of focal brain trauma. Journal of Neurotrauma 21 (2004) 1712-1722
71. Kline A.E., Massucci J.L., Marion D.W., and Dixon C.E. Attenuation of working memory and spatial acquisition deficits after a delayed and chronic bromocriptine treatment regimen in rats subjected to traumatic brain injury by controlled cortical impact. Journal of Neurotrauma 19 (2002) 415-425
72. Kline A.E., Massucci J.L., Zafonte R.D., Dixon C.E., DeFeo J.R., and Rogers E.H. Differential effects of single versus multiple administrations of haloperidol and risperidone on functional outcome after experimental brain trauma. Critical Care Medicine 35 (2007) 919-924
73. Kline A.E., Wagner A.K., Westergom B.P., Malena R.R., Zafonte R.D., Olsen A.S., et al. Acute treatment with the 5-HT(1A) receptor agonist 8-OH-DPAT and chronic environmental enrichment confer neurobehavioral benefit after experimental brain trauma. Behavioural Brain Research 177 (2007) 186-194
74. Kline A.E., Yan H.Q., Bao J., Marion D.W., and Dixon C.E. Chronic methylphenidate treatment enhances water maze performance following traumatic brain injury in rats. Neuroscience Letters 280 (2000) 163-166
75. Konrad K., Gauggel S., Schurek J., Konrad K., Gauggel S., and Schurek J. Catecholamine functioning in children with traumatic brain injuries and children with attention-deficit/hyperactivity disorder. Cognitive Brain Research 16 (2003) 425-433
76. Krimchansky B.Z., Keren O., Sazbon L., and Groswasser Z. Differential time and related appearance of signs, indicating improvement in the state of consciousness in vegetative state traumatic brain injury (VS-TBI) patients after initiation of dopamine treatment. Brain Injury 18 (2004) 1099-1105
77. Lavretsky H., Park S., Siddarth P., Kumar A., and Reynolds III C.F. Methylphenidate-enhanced antidepressant response to citalopram in the elderly: A double-blind, placebo-controlled pilot trial. The American Journal of Geriatric Psychiatry 14 (2006) 181-185
78. Lee M.G., Hassani O.K., Alonso A., Jones B.E., Lee M.G., Hassani O.K., et al. Cholinergic basal forebrain neurons burst with theta during waking and paradoxical sleep. Journal of Neuroscience 25 (2005) 4365-4369
79. Liebetanz D., Nitsche M.A., Tergau F., and Paulus W. Pharmacological approach to the mechanisms of transcranial DC-stimulation-induced after-effects of human motor cortex excitability. Brain 125 (2002) 2238-2247
80. Lin J.S., Roussel B., Akaoka H., Fort P., Debilly G., Jouvet M., et al. Role of catecholamines in the modafinil and amphetamine induced wakefulness: A comparative pharmacological study in the cat. Brain Research 591 (1992) 319-326
81. Lin J.S., Sakai K., Vanni-Mercier G., Jouvet M., Lin J.S., Sakai K., et al. A critical role of the posterior hypothalamus in the mechanisms of wakefulness determined by microinjection of muscimol in freely moving cats. Brain Research 479 (1989) 225-240
82. Lyeth B.G., Jiang J.Y., Gong Q.Z., Hamm R.J., and Young H.F. Effects of mu opioid agonist and antagonist on neurological outcome following traumatic brain injury in the rat. Neuropeptides 29 (1995) 11-19
83. Manns I.D., Alonso A., Jones B.E., Manns I.D., Alonso A., and Jones B.E. Discharge profiles of juxtacellularly labeled and immunohistochemically identified GABAergic basal forebrain neurons recorded in association with the electroencephalogram in anesthetized rats. Journal of Neuroscience 20 (2000) 9252-9263
84. Marcoli M., Cervetto C., Castagnetta M., Sbaffi P., Maura G., Marcoli M., et al. 5-HT control of ischemia-evoked glutamate efflux from human cerebrocortical slices. Neurochemistry International 45 (2004) 687-691
85. Markianos M., Seretis A., Kotsou A., Christopoulos M., Markianos M., Seretis A., et al. CSF neurotransmitter metabolites in comatose head injury patients during changes in their clinical state. Acta Neurochirurgica (Wien) 138 (1996) 57-59
86. Markianos M., Seretis A., Kotsou S., Baltas I., Sacharogiannis H., Markianos M., et al. CSF neurotransmitter metabolites and short-term outcome of patients in coma after head injury. Acta Neurologica Scandinavica 86 (1992) 190-193
87. Martin R.T., and Whyte J. The effects of methylphenidate on command following and yes/no communication in persons with severe disorders of consciousness: A meta-analysis of n-of-1 studies. American Journal of Physical Medicine and Rehabilitation 86 (2007) 613-620
88. Massucci J.L., Kline A.E., Ma X., Zafonte R.D., and Dixon C.E. Time dependent alterations in dopamine tissue levels and metabolism after experimental traumatic brain injury in rats. Neuroscience Letters 372 (2004) 127-131
89. Matsuda W., Komatsu Y., Yanaka K., and Matsumura A. Levodopa treatment for patients in persistent vegetative or minimally conscious states. Neuropsychological Rehabilitation 15 (2005) 414-427
90. McCormick D.A., and McCormick D.A. Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity. Progress in Neurobiology 39 (1992) 337-388
91. McIntosh T.K. Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: A review. Journal of Neurotrauma 10 (1993) 215-261
92. McIntosh T.K., Hayes R.L., DeWitt D.S., Agura V., and Faden A.I. Endogenous opioids may mediate secondary damage after experimental brain injury. The American Journal of Physiology 253 (1987) E565-E574
93. McIntosh T.K., Head V.A., and Faden A.I. Alterations in regional concentrations of endogenous opioids following traumatic brain injury in the cat. Brain Research 425 (1987) 225-233
94. McIntosh T.K., Yu T., Gennarelli T.A., McIntosh T.K., Yu T., and Gennarelli T.A. Alterations in regional brain catecholamine concentrations after experimental brain injury in the rat. Journal of Neurochemistry 63 (1994) 1426-1433
95. Meaney D.F., Smith D.H., Shreiber D.I., Bain A.C., Miller R.T., Ross D.T., et al. Biomechanical analysis of experimental diffuse axonal injury. Journal of Neurotrauma 12 (1995) 689-694
96. Meisner F., Scheller C., Kneitz S., Sopper S., Neuen-Jacob E., Riederer P., et al. Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: A novel pharmacological action of memantine. Neuropsychopharmacology 33 (2008) 2228-2236
97. Meythaler J.M., Brunner R.C., Johnson A., and Novack T.A. Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: A pilot double-blind randomized trial. The Journal of Head Trauma Rehabilitation 17 (2002) 300-313
98. Meythaler J.M., Depalma L., Devivo M.J., Guin-Renfroe S., and Novack T.A. Sertraline to improve arousal and alertness in severe traumatic brain injury secondary to motor vehicle crashes. Brain Injury 15 (2001) 321-331
99. Meythaler J.M., Peduzzi J.D., Eleftheriou E., and Novack T.A. Current concepts: Diffuse axonal injury-associated traumatic brain injury. Archives of Physical Medicine and Rehabilitation 82 (2001) 1461-1471
100. Miller J.D., Farber J., Gatz P., Roffwarg H., German D.C., Miller J.D., et al. Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and walking in the rat. Brain Research 273 (1983) 133-141
101. Mobayed M., and Dinan T.G. Buspirone/prolactin response in post head injury depression. Journal of Affective Disorders 19 (1990) 237-241
102. Moein H., Khalili H.A., and Keramatian K. Effect of methylphenidate on ICU and hospital length of stay in patients with severe and moderate traumatic brain injury. Clinical Neurology and Neurosurgery 108 (2006) 539-542
103. Monte-Silva K., Kuo M.F., Thirugnanasambandam N., Liebetanz D., Paulus W., and Nitsche M.A. Dose-dependent inverted U-shaped effect of dopamine (D2-like) receptor activation on focal and nonfocal plasticity in humans. Journal of Neuroscience 29 (2009) 6124-6131
104. Moore J.L., McAuley J.W., Long L., and Bornstein R. An evaluation of the effects of methylphenidate on outcomes in adult epilepsy patients. Epilepsy and Behavior 3 (2002) 92-95
105. Morrison J.H., Molliver M.E., Grzanna R., Morrison J.H., Molliver M.E., and Grzanna R. Noradrenergic innervation of cerebral cortex: Widespread effects of local cortical lesions. Science 205 (1979) 313-316
106. Moruzzi G., Magoun H.W., Moruzzi G., and Magoun H.W. Brain stem reticular formation and activation of the EEG 1949. Journal of Neuropsychiatry and Clinical Neurosciences 7 (1995) 251-267
107. Ni J.W., Matsumoto K., Li H.B., Murakami Y., Watanabe H., Ni J.W., et al. Neuronal damage and decrease of central acetylcholine level following permanent occlusion of bilateral common carotid arteries in rat. Brain Research 673 (1995) 290-296
108. Nickels J.L., Schneider W.N., Dombovy M.L., and Wong T.M. Clinical use of amantadine in brain injury rehabilitation. Brain Injury 8 (1994) 709-718
109. Nitsche M.A., Fricke K., Henschke U., Schlitterlau A., Liebetanz D., Lang N., et al. Pharmacological modulation of cortical excitability shifts induced by transcranial direct current stimulation in humans. The Journal of Physiology 553 (2003) 293-301
110. Nitsche M.A., Grundey J., Liebetanz D., Lang N., Tergau F., and Paulus W. Catecholaminergic consolidation of motor cortical neuroplasticity in humans. Cerebral Cortex 14 (2004) 1240-1245
111. Nitsche M.A., Lampe C., Antal A., Liebetanz D., Lang N., Tergau F., et al. Dopaminergic modulation of long-lasting direct current-induced cortical excitability changes in the human motor cortex. The European Journal of Neuroscience 23 (2006) 1651-1657
112. Nitsche M.A., and Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. The Journal of Physiology 527 Pt 3 (2000) 633-639
113. Nitsche M.A., and Paulus W. Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans. Neurology 57 (2001) 1899-1901
114. Ohta K., Matsushima E., Matsuura M., Toru M., and Kojima T. Amantadine-induced multiple spike waves on an electroencephalogram of a schizophrenic patient. The World Journal of Biological Psychiatry 1 (2000) 59-64
115. Panula P., Pirvola U., Auvinen S., Airaksinen M.S., Panula P., Pirvola U., et al. Histamine-immunoreactive nerve fibers in the rat brain. Neuroscience 28 (1989) 585-610
116. Parmentier R., Ohtsu H., Djebbara-Hannas Z., Valatx J.L., Watanabe T., Lin J.S., et al. Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: Evidence for the role of brain histamine in behavioral and sleep-wake control. Journal of Neuroscience 22 (2002) 7695-7711
117. Passler M.A., and Riggs R.V. Positive outcomes in traumatic brain injury-vegetative state: Patients treated with bromocriptine. Archives of Physical Medicine and Rehabilitation 82 (2001) 311-315
118. Patkar A.A., Masand P.S., Pae C.U., Peindl K., Hooper-Wood C., Mannelli P., et al. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression. Journal of Clinical Psychopharmacology 26 (2006) 653-656
119. Patrick P.D., Blackman J.A., Mabry J.L., Buck M.L., Gurka M.J., and Conaway M.R. Dopamine agonist therapy in low-response children following traumatic brain injury. Journal of Child Neurology 21 (2006) 879-885
120. Patrick P.D., Buck M.L., Conaway M.R., and Blackman J.A. The use of dopamine enhancing medications with children in low response states following brain injury. Brain Injury 17 (2003) 497-506
121. Peyron C., Tighe D.K., Van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. Journal of Neuroscience 18 (1998) 9996-10015
122. Pimentel L., and Hughes B. Amantadine toxicity presenting with complex ventricular ectopy and hallucinations. Pediatric Emergency Care 7 (1991) 89-92
123. Pop-Jordanov J., and Pop-Jordanova N. Neurophysical substrates of arousal and attention. Cognitive Processing 10 (2009) S71-S79
124. Portas C.M., Bjorvatn B., Fagerland S., Gronli J., Mundal V., Sorensen E., et al. On-line detection of extracellular levels of serotonin in dorsal raphe nucleus and frontal cortex over the sleep/wake cycle in the freely moving rat. Neuroscience 83 (1998) 807-814
125. Povlishock J.T., and Katz D.I. Update of neuropathology and neurological recovery after traumatic brain injury. The Journal of Head Trauma Rehabilitation 20 (2005) 76-94
126. Prasad M.R., Ramaiah C., McIntosh T.K., Dempsey R.J., Hipkens S., Yurek D., et al. Regional levels of lactate and norepinephrine after experimental brain injury. Journal of Neurochemistry 63 (1994) 1086-1094
127. Ramic M., Emerick A.J., Bollnow M.R., O'Brien T.E., Tsai S.Y., and Kartje G.L. Axonal plasticity is associated with motor recovery following amphetamine treatment combined with rehabilitation after brain injury in the adult rat. Brain Research 1111 (2006) 176-186
128. Reid W.M., and Hamm R.J. Post-injury atomoxetine treatment improves cognition following experimental traumatic brain injury. Journal of Neurotrauma 25 (2008) 248-256
129. Reinhard D.L., Whyte J., and Sandel M.E. Improved arousal and initiation following tricyclic antidepressant use in severe brain injury. Archives of Physical Medicine and Rehabilitation 77 (1996) 80-83
130. Rye D.B., Wainer B.H., Mesulam M.M., Mufson E.J., Saper C.B., Rye D.B., et al. Cortical projections arising from the basal forebrain: A study of cholinergic and noncholinergic components employing combined retrograde tracing and immunohistochemical localization of choline acetyltransferase. Neuroscience 13 (1984) 627-643
131. Saniova B., Drobny M., Kneslova L., and Minarik M. The outcome of patients with severe head injuries treated with amantadine sulphate. Journal of Neural Transmission 111 (2004) 511-514
132. Schmidt R.H., Grady M.S., Schmidt R.H., and Grady M.S. Loss of forebrain cholinergic neurons following fluid-percussion injury: Implications for cognitive impairment in closed head injury. Journal of Neurosurgery 83 (1995) 496-502
133. Seliger G.M., Lichtman S.W., and Hornstein A. Naltrexone improves severe posttraumatic abulia. Neurorehabilitation and Neural Repair 12 (1998) 29-31
134. Shames J.L., and Ring H. Transient reversal of anoxic brain injury-related minimally conscious state after zolpidem administration: A case report. Archives of Physical Medicine and Rehabilitation 89 (2008) 386-388
135. Shields W.D., Lake J.L., and Chugani H.T. Amantadine in the treatment of refractory epilepsy in childhood: An open trial in 10 patients. Neurology 35 (1985) 579-581
136. Singh R., McDonald C., Dawson K., Lewis S., Pringle A.M., Smith S., et al. Zolpidem in a minimally conscious state. Brain Injury 22 (2008) 103-106
137. Smith D.H., Meaney D.F., and Shull W.H. Diffuse axonal injury in head trauma. The Journal of Head Trauma Rehabilitation 18 (2003) 307-316
138. Speiser Z., Amitzi-Zonder J., Ashkenazi R., Gitter S., Cohen S., Speiser Z., et al. Central catecholaminergic dysfunction and behavioural disorders following hypoxia in adult rats. Behavioural Brain Research 37 (1990) 19-27
139. Steriade M., Datta S., Pare D., Oakson G., Curro Dossi R.C., Steriade M., et al. Neuronal activities in brain-stem cholinergic nuclei related to tonic activation processes in thalamocortical systems. Journal of Neuroscience 10 (1990) 2541-2559
140. Steriade M., Dossi R.C., Pare D., Oakson G., Steriade M., Dossi R.C., et al. Fast oscillations (20-40 Hz) in thalamocortical systems and their potentiation by mesopontine cholinergic nuclei in the cat. Proceedings of the National Academy of Sciences of the United States of America 88 (1991) 4396-4400
141. Stornetta R.L., Sevigny C.P., Schreihofer A.M., Rosin D.L., Guyenet P.G., Stornetta R.L., et al. Vesicular glutamate transporter DNPI/VGLUT2 is expressed by both C1 adrenergic and nonaminergic presympathetic vasomotor neurons of the rat medulla. The Journal of Comparative Neurology 444 (2002) 207-220
142. Strafella A., Paus T., Barrett J., and Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. The Journal of Neuroscience 21 (2001) RC157
143. Strafella A.P., Paus T., Fraraccio M., and Dagher A. Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex. Brain 126 (2003) 2609-2615
144. Teitelman E. Off-label uses of modafinil. The American Journal of Psychiatry 158 (2001) 1341
145. Tennant Jr. F.S., and Wild J. Naltrexone treatment for postconcussional syndrome. The American journal of Psychiatry 144 (1987) 813-814
146. Thatcher, R. W., & John, E. R. (1977). Functional neuroscience: Foundations of cognitive processes. In: E. R. John & R. W. Thatcher (Eds), (Vol. 1). NJ: L. Erlbaum Assoc.
147. Tower D.B., and McEachern D. Acetylcholine and neuronal activity: Cholinesterase patterns and acetylcholine in cerebrospinal fluids of patients with craniocerebral trauma. Canadian Journal of Research (Section E: Medical Sciences) (1949) 105-119
148. Tsuiki K., Takada A., Nagahiro S., Grdisa M., Diksic M., and Pappius H.M. Synthesis of serotonin in traumatized rat brain. Journal of Neurochemistry 64 (1995) 1319-1325
149. Tsuiki K., Takada A., Nagahiro S., Grdisa M., Diksic M., Pappius H.M., et al. Synthesis of serotonin in traumatized rat brain. Journal of Neurochemistry 64 (1995) 1319-1325
150. Valentino R.J., Page M.E., Curtis A.L., Valentino R.J., Page M.E., and Curtis A.L. Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor. Brain Research 555 (1991) 25-34
151. van der Feltz-Cornelis C.M., and Aldenkamp A.P. Effectiveness and safety of methylphenidate in adult attention deficit hyperactivity disorder in patients with epilepsy: An open treatment trial. Epilepsy Behavior 8 (2006) 659-662
152. Vincent S.R., Hokfelt T., Skirboll L.R., Wu J.Y., Vincent S.R., Hokfelt T., et al. Hypothalamic gamma-aminobutyric acid neurons project to the neocortex. Science 220 (1983) 1309-1311
153. Wagner A.K., Drewencki L.L., Chen X., Santos F.R., Khan A.S., Harun R., et al. Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury. Journal of Neurochemistry 108 (2009) 986-997
154. Wagner A.K., Ren D., Conley Y.P., Ma X., Kerr M.E., Zafonte R.D., et al. Sex and genetic associations with cerebrospinal fluid dopamine and metabolite production after severe traumatic brain injury. Journal of Neurosurgery 106 (2007) 538-547
155. Wagner A.K., Sokoloski J.E., Ren D., Chen X., Khan A.S., Zafonte R.D., et al. Controlled cortical impact injury affects dopaminergic transmission in the rat striatum. Journal of Neurochemistry 95 (2005) 457-465
156. Whyte J., and Myers R. Incidence of clinically significant responses to zolpidem among patients with disorders of consciousness: A preliminary placebo controlled trial. American Journal of Physical Medicine and Rehabilitation 88 (2009) 410-418
157. Wilson M.S., Gibson C.J., and Hamm R.J. Haloperidol, but not olanzapine, impairs cognitive performance after traumatic brain injury in rats. American Journal of Physical Medicine and Rehabilitation 82 (2003) 871-879
158. Wise R.A., Spindler J., deWit H., and Gerberg G.J. Neuroleptic-induced "anhedonia" in rats: Pimozide blocks reward quality of food. Science 201 (1978) 262-264
159. Wroblewski B.A., Leary J.M., Phelan A.M., Whyte J., and Manning K. Methylphenidate and seizure frequency in brain injured patients with seizure disorders. The Journal of Clinical Psychiatry 53 (1992) 86-89
160. Yan H.Q., Kline A.E., Ma X., Li Y., and Dixon C.E. Traumatic brain injury reduces dopamine transporter protein expression in the rat frontal cortex. Neuroreport 13 (2002) 1899-1901
161. Yan H.Q., Ma X., Chen X., Li Y., Shao L., and Dixon C.E. Delayed increase of tyrosine hydroxylase expression in rat nigrostriatal system after traumatic brain injury. Brain Research 1134 (2007) 171-179
162. Zafonte R.D., Lexell J., and Cullen N. Possible applications for dopaminergic agents following traumatic brain injury: Part 2. The Journal of Head Trauma Rehabilitation 16 (2001) 112-116
163. Zhang H., Zhang X., Zhang T., Chen L., Zhang H., Zhang X., et al. Excitatory amino acids in cerebrospinal fluid of patients with acute head injuries. Clinical Chemistry 47 (2001) 1458-1462
164. Ziegler D.R., Cullinan W.E., Herman J.P., Ziegler D.R., Cullinan W.E., and Herman J.P. Distribution of vesicular glutamate transporter mRNA in rat hypothalamus. The Journal of Comparative Neurology 448 (2002) 217-229